- You need to sign in or sign up before continuing.
0
0
8/4/23 at 6:38am
Organization
Moneycontrol
Author
Sunil Shankar Matkar
42 words
0
Comments
Concord Biotech IPO | Quadria Capital-backed Helix will be exiting the company by selling entire shareholding via IPO. Hence, the company will not get any money from the offer.
You are the first to view
https://www.moneycontrol.com/news/business/ipo/jhunjhunwalas-rare-trusts-backed-concord-biotech-ipo-booked-16-on-debut-11097741.html
Create an account
or login to join the discussion